Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Mount Sinai Hospital, Canada | OTHER |
| Wasser Pain Management Centre | UNKNOWN |
| Rasch Foundation | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main purpose of this study is to determine the degree to which Mindfulness-Based Stress Reduction, a group-based psychological therapy that includes mindfulness meditation exercises, reduces depression, anxiety, stress, pain intensity, and interference of pain with daily life among adult chronic pain patients.
The second purpose is to examine the role of attention in improving psychological and physical health for chronic pain patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Mindfulness-Based Stress Reduction | Active Comparator |
| |
| Waitlist Control | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mindfulness-Based Stress Reduction | Behavioral | An 8-week structured group program that was developed to improve psychological and physical symptoms associated with pain. It incorporates a variety of mindfulness meditation exercises including mindful yoga, sitting meditation, and body scan to facilitate attention, acceptance, and awareness of one's experiences. |
| Measure | Description | Time Frame |
|---|---|---|
| Pain disability and Attention | Change in pain disability assessed by the Pain Disability Index (PDI). Change in attention assessed by an adapted version of the Change Blindness Task | Baseline, immediately following treatment, and at 3 months follow up |
| Measure | Description | Time Frame |
|---|---|---|
| Depression | Change in depression assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21) | Baseline, immediately following treatment, and at 3 months follow up |
| Anxiety | Change in anxiety assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nicholas Cepeda, PhD | York University | Principal Investigator |
| Allan Gordon, MD | MOUNT SINAI HOSPITAL | Principal Investigator |
| Denise Paneduro, PhD student | York University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mount Sinai Hospital | Toronto | Ontario | M5G 1X5 | Canada |
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| D059350 | Chronic Pain |
| D003863 | Depression |
| D001008 | Anxiety Disorders |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001526 | Behavioral Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000099024 | Mindfulness-Based Stress Reduction |
| ID | Term |
|---|---|
| D064866 | Mindfulness |
| D015928 | Cognitive Behavioral Therapy |
| D001521 | Behavior Therapy |
| D011613 | Psychotherapy |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Baseline, immediately following treatment, and at 3 months follow up |
| Stress | Change in stress assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21) | Baseline, immediately following treatment, and at 3 months follow up |
| Mindfulness | Change in mindfulness assessed by the Five Facet Mindfulness Questionnaire (FFMQ) and Mindful Attention Awareness Scale (MAAS) | Baseline, immediately following treatment, and at 3 months follow up |
| Acceptance | Change in acceptance assessed by the Chronic Pain Acceptance Questionnaire (CPAQ) | Baseline, immediately following treatment, and at 3 months follow up |
| Pain Intensity | Change in pain intensity assessed by the Short-form McGill Pain Questionnaire (SF-MPQ-2). | Baseline, immediately following treatment, and at 3 months follow up |
| D001519 | Behavior |
| D001523 | Mental Disorders |
| D004191 |
| Behavioral Disciplines and Activities |